Report Detail
Global Artificial Intelligence Drug R&D Market 2020 by Company, Regions, Type and Application, Forecast to 2025
- RnM4087181 |
- 02 July, 2020 |
- Global |
- 109 Pages |
- GIR (Global Info Research) |
- Service & Software
Market Overview
The Artificial Intelligence Drug R&D market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Artificial Intelligence Drug R&D market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Artificial Intelligence Drug R&D market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Artificial Intelligence Drug R&D market has been segmented into:
AI Platfrom
Analytics Service
By Application, Artificial Intelligence Drug R&D has been segmented into:
Drug Discovery
Precision Medicine
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Artificial Intelligence Drug R&D market presented in the report. This section sheds light on the sales growth of different regional and country-level Artificial Intelligence Drug R&D markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Artificial Intelligence Drug R&D market.
The report offers in-depth assessment of the growth and other aspects of the Artificial Intelligence Drug R&D market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Artificial Intelligence Drug R&D Market Share Analysis
Artificial Intelligence Drug R&D competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Artificial Intelligence Drug R&D sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Artificial Intelligence Drug R&D sales, revenue and market share for each player covered in this report.
The major players covered in Artificial Intelligence Drug R&D are:
IBM Watson
QuantumBlack
Gatehouse Bio
BioXel
Cyclica Inc
Insilico Medicine
Phenomic AI
Genpact Cora
Google DeepMind
Nq Medical
Palantir Technologies
Among other players domestic and global, Artificial Intelligence Drug R&D market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Artificial Intelligence Drug R&D Market Overview
- 1.1 Product Overview and Scope of Artificial Intelligence Drug R&D
- 1.2 Classification of Artificial Intelligence Drug R&D by Type
- 1.2.1 Global Artificial Intelligence Drug R&D Revenue by Type: 2015 VS 2019 VS 2025
- 1.2.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Type in 2019
- 1.2.3 AI Platfrom
- 1.2.4 Analytics Service
- 1.3 Global Artificial Intelligence Drug R&D Market by Application
- 1.3.1 Overview: Global Artificial Intelligence Drug R&D Revenue by Application: 2015 VS 2019 VS 2025
- 1.3.2 Drug Discovery
- 1.3.3 Precision Medicine
- 1.4 Global Artificial Intelligence Drug R&D Market by Regions
- 1.4.1 Global Artificial Intelligence Drug R&D Market Size by Regions: 2015 VS 2019 VS 2025
- 1.4.2 Global Market Size of Artificial Intelligence Drug R&D (2015-2025)
- 1.4.3 North America (USA, Canada and Mexico) Artificial Intelligence Drug R&D Status and Prospect (2015-2025)
- 1.4.4 Europe (Germany, France, UK, Russia and Italy) Artificial Intelligence Drug R&D Status and Prospect (2015-2025)
- 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artificial Intelligence Drug R&D Status and Prospect (2015-2025)
- 1.4.6 South America (Brazil, Argentina, Colombia) Artificial Intelligence Drug R&D Status and Prospect (2015-2025)
- 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artificial Intelligence Drug R&D Status and Prospect (2015-2025)
2 Company Profiles
- 2.1 IBM Watson
- 2.1.1 IBM Watson Details
- 2.1.2 IBM Watson Major Business
- 2.1.3 IBM Watson SWOT Analysis
- 2.1.4 IBM Watson Product and Services
- 2.1.5 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.2 QuantumBlack
- 2.2.1 QuantumBlack Details
- 2.2.2 QuantumBlack Major Business
- 2.2.3 QuantumBlack SWOT Analysis
- 2.2.4 QuantumBlack Product and Services
- 2.2.5 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.3 Gatehouse Bio
- 2.3.1 Gatehouse Bio Details
- 2.3.2 Gatehouse Bio Major Business
- 2.3.3 Gatehouse Bio SWOT Analysis
- 2.3.4 Gatehouse Bio Product and Services
- 2.3.5 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.4 BioXel
- 2.4.1 BioXel Details
- 2.4.2 BioXel Major Business
- 2.4.3 BioXel SWOT Analysis
- 2.4.4 BioXel Product and Services
- 2.4.5 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.5 Cyclica Inc
- 2.5.1 Cyclica Inc Details
- 2.5.2 Cyclica Inc Major Business
- 2.5.3 Cyclica Inc SWOT Analysis
- 2.5.4 Cyclica Inc Product and Services
- 2.5.5 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.6 Insilico Medicine
- 2.6.1 Insilico Medicine Details
- 2.6.2 Insilico Medicine Major Business
- 2.6.3 Insilico Medicine Product and Services
- 2.6.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.7 Phenomic AI
- 2.7.1 Phenomic AI Details
- 2.7.2 Phenomic AI Major Business
- 2.7.3 Phenomic AI Product and Services
- 2.7.4 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.8 Genpact Cora
- 2.8.1 Genpact Cora Details
- 2.8.2 Genpact Cora Major Business
- 2.8.3 Genpact Cora Product and Services
- 2.8.4 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.9 Google DeepMind
- 2.9.1 Google DeepMind Details
- 2.9.2 Google DeepMind Major Business
- 2.9.3 Google DeepMind Product and Services
- 2.9.4 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.10 Nq Medical
- 2.10.1 Nq Medical Details
- 2.10.2 Nq Medical Major Business
- 2.10.3 Nq Medical Product and Services
- 2.10.4 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
- 2.11 Palantir Technologies
- 2.11.1 Palantir Technologies Details
- 2.11.2 Palantir Technologies Major Business
- 2.11.3 Palantir Technologies Product and Services
- 2.11.4 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
- 3.1 Global Artificial Intelligence Drug R&D Revenue and Share by Players (2015-2020)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Artificial Intelligence Drug R&D Players Market Share
- 3.2.2 Top 10 Artificial Intelligence Drug R&D Players Market Share
- 3.3 Market Competition Trend
4 Market Size by Regions
- 4.1 Global Artificial Intelligence Drug R&D Revenue and Market Share by Regions
- 4.2 North America Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 4.3 Europe Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 4.4 Asia-Pacific Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 4.5 South America Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 4.6 Middle East & Africa Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
5 North America Artificial Intelligence Drug R&D Revenue by Countries
- 5.1 North America Artificial Intelligence Drug R&D Revenue by Countries (2015-2020)
- 5.2 USA Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 5.3 Canada Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 5.4 Mexico Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
6 Europe Artificial Intelligence Drug R&D Revenue by Countries
- 6.1 Europe Artificial Intelligence Drug R&D Revenue by Countries (2015-2020)
- 6.2 Germany Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 6.3 UK Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 6.4 France Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 6.5 Russia Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 6.6 Italy Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Artificial Intelligence Drug R&D Revenue by Countries
- 7.1 Asia-Pacific Artificial Intelligence Drug R&D Revenue by Countries (2015-2020)
- 7.2 China Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 7.3 Japan Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 7.4 Korea Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 7.5 India Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 7.6 Southeast Asia Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
8 South America Artificial Intelligence Drug R&D Revenue by Countries
- 8.1 South America Artificial Intelligence Drug R&D Revenue by Countries (2015-2020)
- 8.2 Brazil Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 8.3 Argentina Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Artificial Intelligence Drug R&D by Countries
- 9.1 Middle East & Africa Artificial Intelligence Drug R&D Revenue by Countries (2015-2020)
- 9.2 Saudi Arabia Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 9.3 UAE Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 9.4 Egypt Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
- 9.5 South Africa Artificial Intelligence Drug R&D Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
- 10.1 Global Artificial Intelligence Drug R&D Revenue and Market Share by Type (2015-2020)
- 10.2 Global Artificial Intelligence Drug R&D Market Forecast by Type (2019-2024)
- 10.3 AI Platfrom Revenue Growth Rate (2015-2025)
- 10.4 Analytics Service Revenue Growth Rate (2015-2025)
11 Global Artificial Intelligence Drug R&D Market Segment by Application
- 11.1 Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2015-2020)
- 11.2 Artificial Intelligence Drug R&D Market Forecast by Application (2019-2024)
- 11.3 Drug Discovery Revenue Growth (2015-2020)
- 11.4 Precision Medicine Revenue Growth (2015-2020)
12 Global Artificial Intelligence Drug R&D Market Size Forecast (2021-2025)
- 12.1 Global Artificial Intelligence Drug R&D Market Size Forecast (2021-2025)
- 12.2 Global Artificial Intelligence Drug R&D Market Forecast by Regions (2021-2025)
- 12.3 North America Artificial Intelligence Drug R&D Revenue Market Forecast (2021-2025)
- 12.4 Europe Artificial Intelligence Drug R&D Revenue Market Forecast (2021-2025)
- 12.5 Asia-Pacific Artificial Intelligence Drug R&D Revenue Market Forecast (2021-2025)
- 12.6 South America Artificial Intelligence Drug R&D Revenue Market Forecast (2021-2025)
- 12.7 Middle East & Africa Artificial Intelligence Drug R&D Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Data Source
- 14.3 Disclaimer
Summary:
Get latest Market Research Reports on Artificial Intelligence Drug R&D. Industry analysis & Market Report on Artificial Intelligence Drug R&D is a syndicated market report, published as Global Artificial Intelligence Drug R&D Market 2020 by Company, Regions, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of Artificial Intelligence Drug R&D market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
